2013 Chabner Colloquium - DAY 2

Tuesday, October 29, 2013 at 7:00am to 3:30pm

2013 Chabner Colloquium - DAY 2

The Society for Translational Oncology (STO) and the Massachusetts General Hospital Cancer Center (MGHCC), will host the 2013 Chabner Colloquium focusing on topics that bring cancer biology to clinical application.

This is a unique opportunity to share insights and perspectives between investigators and industry professionals working on novel therapeutic targets that will bring exciting changes in oncology practice in the years ahead.

 

Day 1 session topics include:

- Dealing with resistance to targeted therapy

- The biology of unique tumors

- Drug development based on new signaling pathways

  •  

We are honored to have Dr. Louis Staudt, Head of the Molecular Biology of Lymphoid Malignancies Section and Deputy Branch Chief of the Center for Cancer Research, National Cancer Institute, joining us on Monday, October 28 to lecture on New Targets for Non-Hodgkin Lymphoma.

The day concludes with a forum of junior faculty members from Dana-Farber/Harvard Cancer Center sharing their recent work.

 

Day 2 will focus on:

- Biology and treatment - melanoma and breast cancer

- Stem cells and circulating tumor cells

- Special symposium: Prostate Cancer: Progress and Promise, Part IV

 

For meeting information or to register, click here.

Share
Subscribe
Event Type

Clinical Research

Website

http://sto-mgh-cc2013.eventbrite.com

Cost

$150.00

Event Contact Name

Gwen White

Event Contact Email

gwhite6@partners.org

Event Contact Phone

617-724-3200

Recent Activity

People Going


NCI CCC